552 related articles for article (PubMed ID: 28074057)
1. Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections.
Brown P; Dawson MJ
J Antibiot (Tokyo); 2017 Apr; 70(4):386-394. PubMed ID: 28074057
[TBL] [Abstract][Full Text] [Related]
2. Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.
Poirel L; Jayol A; Nordmann P
Clin Microbiol Rev; 2017 Apr; 30(2):557-596. PubMed ID: 28275006
[TBL] [Abstract][Full Text] [Related]
3. Polymyxins and their novel derivatives.
Vaara M
Curr Opin Microbiol; 2010 Oct; 13(5):574-81. PubMed ID: 20869908
[TBL] [Abstract][Full Text] [Related]
4. Emergence of polymyxin resistance in Gram-negative bacteria.
Olaitan AO; Li J
Int J Antimicrob Agents; 2016 Dec; 48(6):581-582. PubMed ID: 27939183
[No Abstract] [Full Text] [Related]
5. Resistance to polymyxins: Mechanisms, frequency and treatment options.
Falagas ME; Rafailidis PI; Matthaiou DK
Drug Resist Updat; 2010; 13(4-5):132-8. PubMed ID: 20843473
[TBL] [Abstract][Full Text] [Related]
6. Polymyxins: a review of the current status including recent developments.
Kwa AL; Tam VH; Falagas ME
Ann Acad Med Singap; 2008 Oct; 37(10):870-83. PubMed ID: 19037522
[TBL] [Abstract][Full Text] [Related]
7. Polymyxin antibiotics for gram-negative infections.
Arnold TM; Forrest GN; Messmer KJ
Am J Health Syst Pharm; 2007 Apr; 64(8):819-26. PubMed ID: 17420197
[TBL] [Abstract][Full Text] [Related]
8. Teaching 'old' polymyxins new tricks: new-generation lipopeptides targeting gram-negative 'superbugs'.
Velkov T; Roberts KD; Nation RL; Wang J; Thompson PE; Li J
ACS Chem Biol; 2014 May; 9(5):1172-7. PubMed ID: 24601489
[TBL] [Abstract][Full Text] [Related]
9. Is it time to move away from polymyxins?: evidence and alternatives.
Soman R; Bakthavatchalam YD; Nadarajan A; Dwarakanathan HT; Venkatasubramanian R; Veeraraghavan B
Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):461-475. PubMed ID: 33009595
[TBL] [Abstract][Full Text] [Related]
10. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City.
Quale J; Shah N; Kelly P; Babu E; Backer M; Rosas-Garcia G; Salamera J; George A; Bratu S; Landman D
Microb Drug Resist; 2012 Apr; 18(2):132-6. PubMed ID: 22196342
[TBL] [Abstract][Full Text] [Related]
11. Clinical translation of polymyxin-based combination therapy: Facts, challenges and future opportunities.
Zhang X; Guo F; Shao H; Zheng X
J Infect; 2017 Feb; 74(2):118-130. PubMed ID: 27998750
[TBL] [Abstract][Full Text] [Related]
12. [Aminoglycosides and polymyxins].
Molina J; Cordero E; Palomino J; Pachón J
Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):178-88. PubMed ID: 19303668
[TBL] [Abstract][Full Text] [Related]
13. Polymyxin Derivatives that Sensitize Gram-Negative Bacteria to Other Antibiotics.
Vaara M
Molecules; 2019 Jan; 24(2):. PubMed ID: 30641878
[TBL] [Abstract][Full Text] [Related]
14. Will new antimicrobials overcome resistance among Gram-negatives?
Bassetti M; Ginocchio F; Mikulska M; Taramasso L; Giacobbe DR
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):909-22. PubMed ID: 21973303
[TBL] [Abstract][Full Text] [Related]
15. Polymyxin derivatives: a patent evaluation (WO2012168820).
Wu H; Teng P; Niu Y; Li Q; Cai J
Expert Opin Ther Pat; 2013 Aug; 23(8):1075-81. PubMed ID: 23806121
[TBL] [Abstract][Full Text] [Related]
16. Polymyxin B: a new strategy for multidrug-resistant Gram-negative organisms.
Yuan Z; Tam VH
Expert Opin Investig Drugs; 2008 May; 17(5):661-8. PubMed ID: 18447592
[TBL] [Abstract][Full Text] [Related]
17. Treatment of infections caused by Gram-negative pathogens: current status on the pharmacokinetics/pharmacodynamics of parenteral and inhaled polymyxins in patients.
Lin YW; Aye SM; Rao G; Zhou QT; Chan HK; Li J
Int J Antimicrob Agents; 2020 Dec; 56(6):106199. PubMed ID: 33075510
[TBL] [Abstract][Full Text] [Related]
18. Multidrug-Resistant Gram-Negative Pathogens: The Urgent Need for 'Old' Polymyxins.
Paterson DL; Bonomo RA
Adv Exp Med Biol; 2019; 1145():9-13. PubMed ID: 31364068
[TBL] [Abstract][Full Text] [Related]
19. The current state of multidrug-resistant gram-negative bacilli in North America.
Nicasio AM; Kuti JL; Nicolau DP
Pharmacotherapy; 2008 Feb; 28(2):235-49. PubMed ID: 18225969
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.
Velkov T; Roberts KD; Nation RL; Thompson PE; Li J
Future Microbiol; 2013 Jun; 8(6):711-24. PubMed ID: 23701329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
